Robert Udelsman, MD

Dr. Lewin is a radiation oncologist who treats a variety of cancers, with a special interest in breast cancer. He is a clinical professor of radiation oncology at the University of Miami Miller School of Medicine and served as medical director of radiation oncology at Baptist Hospital from 1987 to 2016.

Matthew Hall, M.D., is the lead pediatric radiation oncologist at Miami Cancer Institute, a part of Baptist Health South Florida. He is Board certified in radiation oncology and has extensive training and experience in standard photon therapy and proton therapy – a highly advanced form of radiation technology that targets cancer cells with pencil-beam scanning precision while sparing the surrounding healthy tissue. His clinical specialty and research focus on innovative ways to treat cancer with radiation therapy while minimizing long-term side effects. He has authored more than a dozen scientific articles in his specialty and has presented posters and abstracts at numerous national and international meetings. Dr. Hall is a member the American Society for Radiation Oncology, the American College of Radiation and several other scientific and medical societies. He received his medical degree from the University of Illinois College of Medicine in Peoria, graduating with honors. He also earned a master’s degree in business administration from the University of Illinois Liautaud Graduate School of Business in Chicago. He served as chief resident during his radiation oncology residency at City of Hope National Medical Center in Duarte. He continued his postdoctoral training at the University of Florida Health Proton Therapy Institute in Jacksonville, completing a fellowship in adult radiation oncology and a fellowship in pediatric radiation oncology. During his schooling, Dr. Hall was inducted into such prestigious honor societies as Phi Beta Kappa and Alpha Omega Alpha Honor Medical Society.

An internationally renowned expert in the application of both autologous and allogeneic stem cell transplantation for the treatment of leukemia, myelodysplastic syndrome, multiple myeloma and other lymphoproliferative diseases, Guenther Koehne, M.D., Ph.D., serves as deputy director and chief of Stem Cell Transplantation, Hematologic Oncology and Benign Hematology at Miami Cancer Institute, part of Baptist Health South Florida. Prior to joining the Institute in 2017, he was a leading physician in adult bone marrow transplantation at Memorial Sloan Kettering Cancer Center in New York and an Associate Professor of medicine at Weill Cornell Medical College. Dr. Koehne is recognized for his work in adoptive immunotherapeutic approaches with antigen-specific, donor-derived T lymphocytes to treat viral complications following allogeneic transplants and the development of novel treatments for high-risk multiple myeloma, minimal residual disease of leukemia and relapsed disease post-allogeneic stem cell transplantation. A physician-scientist, Dr. Koehne has led the development and growth of the Institute’s outpatient and inpatient blood and bone marrow transplant program and is involved in numerous groundbreaking clinical trials.Dr. Koehne is Board certified in internal medicine and medical oncology. He received his medical degree and Ph.D. from Medical University of Hamburg, Germany, where he also trained as a resident in internal medicine. He completed an additional internal medicine residency at Rush University Medical Center in Chicago. His extensive training also includes a medical oncology/hematology fellowship at Memorial Sloan Kettering Cancer Center and a research fellowship in the Immunology Program at the Sloan Kettering Institute for Cancer Research, Allogeneic Bone Marrow Transplantation Service. Dr. Koehne is a member of the American Society of Hematology, American Society for Blood and Marrow Transplantation and the American Society of Clinical Oncology. He champions the Leukemia & Lymphoma Society and has served as Chairman of the Light the Night Walk, the organization’s largest fundraiser.